Compare UHG & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UHG | PAVM |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | 195 | 41 |
| Industry | Homebuilding | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8M | 65.5M |
| IPO Year | N/A | N/A |
| Metric | UHG | PAVM |
|---|---|---|
| Price | $1.22 | $7.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $65.00 |
| AVG Volume (30 Days) | ★ 137.5K | 10.7K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $0.21 |
| 52 Week High | $4.78 | $28.44 |
| Indicator | UHG | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 31.13 |
| Support Level | $1.15 | $0.34 |
| Resistance Level | $1.22 | $10.98 |
| Average True Range (ATR) | 0.02 | 0.35 |
| MACD | 0.01 | -0.14 |
| Stochastic Oscillator | 70.00 | 4.90 |
United Homes Group Inc designs, builds and sells homes in high growth markets, including South Carolina, North Carolina, and Georgia. UHG employs a land-light operating, with a focus on the design, construction and sale of entry-level, first, second and third move-up single-family houses. The company principally builds detached single-family houses, and, to a lesser extent, attached single-family houses, including duplex houses and town houses. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.